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Thyroid carcinoma is the most common endocrine malignant tumor and accounts for
1% of all new malignant diseases. Among all types and subtypes of thyroid cancers
that have been described so far, papillary thyroid carcinoma is the most frequent.
The standard management treatment of these tumors consists of surgery, followed
by radioiodine treatment in case of high risk of relapse. The most aggressive forms
are commonly treated by chemotherapy, radiotherapy or experimental drug testing.
We recently reported the case of a patient presenting an anaplastic thyroid
carcinoma with lung metastases. Fluorescence in situ hybridization analysis allowed
us to detect a rearrangement of the anaplastic lymphoma kinase (ALK) gene in both
tumors. The patient was treated with crizotinib and presented an excellent drug
response. We present here the subsequent investigations carried out to further
characterize this genetic alteration and to assess the prevalence of ALK
rearrangements in thyroid lesions. High resolution array-comparative genomic
hybridization data complemented by RT-PCR and sequencing analyses, allowed us to
demonstrate the presence of a STRN/ALK fusion. The STRN/ALK transcript consisted
of the fusion between exon 3 of STRN and exon 20 of ALK. Subsequent screening of
75 various thyroid tumors by RT-PCR revealed that 2 out of 29 papillary thyroid
carcinomas exhibited the same fusion transcript. None was detected in other types of
malignant or benign thyroid lesions analyzed. These findings could pave the way for
the development of new targeted therapeutic strategies in the treatment of papillary
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